This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Swiftmelt 1515-I meets performance requirements and secures skin attachment
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
The company is one of the most profitable companies manufacturing speciality chemicals in India
Cipla and Ethris partner for the development of mRNA-based therapies
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Subscribe To Our Newsletter & Stay Updated
